Troxerutin

Producer:Shaanxi Huifeng Pharmaceutical Co., Ltd., founded in January 2000, is a high-tech enterprise group specializing in the R & D, production and sales of plant extracts, pharmaceutical raw materials and biopharmaceuticals.

The company has successively passed ISO9001:2000 quality system certification, national GMP certification and European cos certification, and obtained the green industry standard quality certificate for the import and export of medicinal plants and preparations issued by China Medical Insurance import and Export Chamber of Commerce.

Staff size:About 50 persons

Registered capital:RMB 56 million

Producer:Shandong Duanxintang Dayu Pharmaceutical Co., Ltd.was founded in 2003, covering an area of 130 mu. The company took the lead in passing the national GMP certification in 2004. The annual production capacity of its main products is: 800 tons of refined rutin, 650 tons of troxerutin (injection grade), 900 tons of troxerutin (oral grade), 36 million bags of granules, 2.6 billion tablets and 100 million pieces of water injection. The annual extraction capacity of traditional Chinese medicine is 1200 tons.

Staff size:100-499 persons

Registered capital:RMB 30.67 million

Producer:Sichuan Xieli Pharmaceutical Co., Ltd., founded in the 1980s, is a GMP pharmaceutical enterprise specializing in the R & D and production of API in China.

It has three production bases with a total of 3245 square meters of 100000 purification workshops, successfully applied for DMF registration and CEP in Europe, America and Japan, and has passed the official GMP certification at home and abroad such as EDQM, FDA, PMDA, nmpa, cofepris, MHRA and so on. The company insists on long-term investment in EHS and has passed PSCI on-site audit. Xieli has 23 products with domestic approval numbers, and has long-term cooperation with major pharmaceutical manufacturers in China.

Registered capital:RMB 15 million

Producer:Yantai Luyin Pharmaceutical Co., Ltd. mainly produces plant APIs and various preparations. It is the largest extraction base of plant APIs in Shandong Province. Modern production conditions and perfect QA system create high-quality products for the society. The company has passed ISO9000 quality system certification and national GMP certification. Guided by product development, the company has its own scientific research institute and unique professional technology, and jointly develops high, fine and advanced products with domestic colleges and universities and scientific research institutions. There are 11 kinds of API, 8 dosage forms and more than 90 varieties of product series.

Registered capital:RMB 132.074 million

Producer:Shanxi Jinhua Huixing Pharmaceutical Co., Ltd. was jointly established by Shanxi Jinhua Pharmaceutical Co., Ltd. and Hong Kong in 2004. It covers an area of 35880m2.

In June 1999, the preparation workshop meeting the "GMP" standard was put into operation and achieved results. On December 8, Shanxi Province was the first to pass the "GMP" certification of tablets and capsules by the National Drug Certification Commission.   At present, the main products are three dosage forms and a total of 47 drug varieties.

Producer:Qingdao Jinfeng Pharmaceutical Co., Ltd., founded in 1979, is a pharmaceutical enterprise jointly established with Taiwan businessmen.The business scope of the company includes the production of small volume injections (including antitumor drugs), large volume injections, etc.

Staff size:100-199 persons

Registered capital:USD 686 thousand and 200

Producer:Shanghai Xiandai Hasen(Shangqiu) Pharmaceutical Co., Ltd.is a holding company invested and established by the listed company Shanghai Hyundai Pharmaceutical Co., Ltd. (stock code 600420). The major shareholder is China Pharmaceutical Group Corporation. It is a pharmaceutical enterprise built in strict accordance with the modern enterprise system and the requirements of national GMP. It is a diversified enterprise integrating drug R & D, production and sales Modern national essential drug production base. The company covers an area of more than 500 mu, has a registered capital of 83.29 million yuan, a total asset of more than 600 million yuan, and has more than 1600 employees, including more than 800 professional and technical personnel; The company has obtained 163 drug production approval products, and has GMP production lines for small volume injections, oral solid preparations (tablets, capsules, granules), APIs and other dosage forms. The annual production capacity of small volume injections is 4 billion tubes, 6 billion tablets (granules and bags) of oral solid preparations and 1200 tons of API.

Staff size:1000-1999 persons

Registered capital:RMB 83.29 million

Producer:Yabao Pharmaceutical Group Co., Ltd. is a group company with a history of more than 40 years. It was listed on the Shanghai Stock Exchange in 2002. The company integrates the R & D, production, sales, logistics and planting of traditional Chinese medicine of drugs and great health products. It has 23 subsidiaries and nearly 6000 employees.

The company has 9 production bases, 4 research bases and 4 large and medium-sized medicinal material planting bases. Among them, 6 API production lines, 2 preparation production lines and 1 plastic bottle production line have passed the certification of developed countries such as the United States, Germany and Japan.

Staff size:About 6000 persons

Registered capital:RMB 770 million

Producer:Shanxi Tongji Pharmaceutical Co., Ltd., established in April 2005, is an enterprise specializing in the production of API. The company integrates scientific research, pilot test and production, and has strong scientific research and development and achievement transformation ability. The company's advanced production equipment provides a solid material foundation for the synthesis of high-quality and efficient API; Perfect testing equipment; It has professional scientific research and technical personnel and rich pharmaceutical expert resources. The production management, quality control and quality inspection personnel have relevant professional skills and knowledge. At the same time, the production personnel are trained in production skills and quality control regularly or irregularly, so as to provide a reliable guarantee for the quality of drugs! Strictly control the product quality according to the enterprise's internal control standards, and prevent unqualified products from leaving the factory.

Staff size:About 50 persons

Registered capital:RMB 83.1 million

Producer:Duoduo Pharmaceutical Co., Ltd. is the holding company of Beijing Zhongguancun Technology Development (holding) Co., Ltd., a listed company. The company is located on the Bank of the beautiful Songhua River and has gone through more than 50 years so far. The company covers an area of more than 100000 square meters, plant construction area of more than 50000 square meters and total assets of 300 million yuan.

The company has solid preparations β- The six main workshops of lactam solid preparation, liquid preparation, external preparation, API and traditional Chinese medicine extraction can produce 410 million water injections and 4 billion solid preparations (tablets) per year. The production equipment of the company is advanced, and all of them realize automatic operation. The company has 10 dosage forms and 143 varieties, all of which have passed the new national GMP certification.

Registered capital:RMB 23 million 342 thousand and 500

Producer:Changchun Dazheng Tec-Phar Co., Ltd.is located in Changchun Economic Development Zone, covering an area of 100000 square meters and a construction area of more than 40000 square meters. It is designed and built in strict accordance with GMP standards. It has an annual production capacity of 2 billion tablets, 150 million hard capsules, 60 million bags of granules, 30 million water injections and 30 million mixtures, It also has the processing capacity of 3000 tons of traditional Chinese medicine extraction.

Registered capital:100-199 persons

Producer:Topfond Pharmaceutical Co., Ltd.is a large-scale large-scale enterprise integrating the production and sales of finished products, chemical synthesis raw materials and biological fermentation raw materials, and pharmaceutical management. Comprehensive pharmaceutical company.

Topfond Pharmaceutical was founded in 1969. In December 2000, the A shares of Topfond  Pharmaceutical was listed on the Shanghai Stock Exchange. After more than 40 years of hard work, the company has grown from small to large, from weak to strong, and has now developed into a large pharmaceutical group with 5 subsidiaries, 4 production plants and 1 national technology development center. It has 4000 employees. There are more than 4 people with total assets of more than 4 billion yuan. The company's production scale of finished preparations and fermentation tonnage of antibiotic raw materials are among the best in the industry in the country. Joined China General Technology Group in August 2008. In July 2013, it successfully realized the merger and absorption of shares exchange with China National Pharmaceutical and Health Industry Co., Ltd., and was officially included in China Pharmaceutical Management.

Topfond Pharmaceutical produces and reserves more than 10 types and nearly 600 varieties and specifications of products. It has an oral solid preparation workshop with an annual production capacity of nearly 6 billion tablets (tablets), the scale is among the forefront of the industry; the antibiotic fermentation tonnage is 12,000m³. The raw materials and some preparation products are exported to more than 20 countries and regions including Western Europe, Southeast Asia, the Middle East, North Africa, India, etc., and an international marketing network is initially formed.

Staff size:2000-2999 persons

Registered capital:RMB 420 million